Tonix Pharmaceuticals Holding (TNXP) Gains from Investment Securities (2024)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Gains from Investment Securities of $855000.0 for Q2 2024, up 112.21% quarter-over-quarter from -$7.0 million in Q1 2024.
Tonix Pharmaceuticals Holding (TNXP) Gains from Investment Securities (2024) Analysis & Trends
Tonix Pharmaceuticals Holding's Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $855000.0 for Q2 2024.
- In Q2 2024, Gains from Investment Securities changed N/A year-over-year to $855000.0; the TTM figure through Dec 2024 stood at -$6.1 million (changed N/A YoY), while the FY2024 annual figure was -$6.1 million, down 2273.14% from the prior year.
- Gains from Investment Securities for Q2 2024 stood at $855000.0, up from -$7.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $855000.0 in Q2 2024, with the low at -$7.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 855,000.00 |
| Mar 31, 2024 | -7.01 Mn |
| Mar 31, 2024 | -7.01 Mn |